Apalutamide is a nonsteroidal androgen receptor antagonist used as a pharmaceutical raw material for the manufacturing of medications indicated in castration-resistant prostate cancer. It selectively binds to the androgen receptor ligand-binding domain, blocking nuclear translocation and transcription of androgen receptor gene targets.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 956104-40-8
Apalutamide Dithio Impurity
pharmaceutical raw material
Apalutamide Di-(2-fluoro-N-methylbenzamide)
pharmaceutical raw material
Apalutamide metabolite M2
pharmaceutical raw material
Methyl 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoate
research compound
Ranolazine
pharmaceutical raw material
Ranolazine hydrochloride
pharmaceutical raw material
Fluindione
pharmaceutical raw material
(7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester
pharmaceutical raw material
4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide
HJBWBFZLDZWPHF-UHFFFAOYSA-N
CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F